SCHEMBL8295689

SCHEMBL8295689

CC(C)CCc1ccc(C(N)=O)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 1/20 0.44
▸ SLC6A4 P31645 5/20 0.44
▸ SLC6A2 P23975 4/20 0.44
▸ SLC6A3 Q01959 4/20 0.44
▸ LMNA P02545 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HPGD P15428 1/20 0.41
▸ RORC P51449 2/20 0.41
▸ EPHX1 P07099 1/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ BCAT2 O15382 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ PTGS1 P23219 2/20 0.38
▸ PTGS2 P35354 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8293311 0.86 TSHR (0.50) HPGDKDM4EPTGS1PTGS2
SCHEMBL25016679 0.84 OPRK1 (0.51) OPRK1SLC6A4SLC6A2SLC6A3HPGD
SCHEMBL14037612 0.82 SLC6A4 (0.47) OPRK1SLC6A4SLC6A2SLC6A3LMNA
SCHEMBL8295723 0.82 ALDH1A1 (0.46) LMNASMN1; SMN2HPGDKDM4E
SCHEMBL1696442 0.80 SLC6A4 (0.50) OPRK1SLC6A4SLC6A2SLC6A3LMNA
SCHEMBL27778791 0.79 SLC6A4 (0.43) OPRK1SLC6A4SLC6A2SLC6A3PARP1
SCHEMBL2260387 0.78 SLC6A4 (0.46) OPRK1SLC6A4SLC6A2SLC6A3LMNA
SCHEMBL27722327 0.76 SLC6A4 (0.47) OPRK1SLC6A4SLC6A2SLC6A3LMNA
SCHEMBL436854 0.74 IDO1 (0.50) SLC6A4SLC6A2SLC6A3LMNAEPHX1
SCHEMBL19254203 0.73 SLC6A2 (0.42) SLC6A4SLC6A2SLC6A3KCNH2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449447-B2 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2008-11-11 — — US disclosed
WO-2005021584-A2 NOVEL PEPTIDOMIMETIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-03-10 — — WO disclosed
Send feedback